Assertio/$ASRT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Assertio
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
Ticker
$ASRT
Sector
Primary listing
Employees
58
Headquarters
Website
Assertio Metrics
BasicAdvanced
$78M
-
-$0.45
0.35
-
Price and volume
Market cap
$78M
Beta
0.35
52-week high
$1.32
52-week low
$0.51
Average daily volume
239K
Financial strength
Current ratio
1.586
Quick ratio
1.301
Long term debt to equity
42.917
Total debt to equity
43.202
Interest coverage (TTM)
-11.52%
Profitability
EBITDA (TTM)
-3.267
Gross margin (TTM)
66.08%
Net profit margin (TTM)
-36.97%
Operating margin (TTM)
-30.08%
Effective tax rate (TTM)
-0.17%
Revenue per employee (TTM)
$2,020,000
Management effectiveness
Return on assets (TTM)
-7.96%
Return on equity (TTM)
-38.40%
Valuation
Price to revenue (TTM)
0.664
Price to book
0.84
Price to tangible book (TTM)
2.5
Price to free cash flow (TTM)
4.305
Free cash flow yield (TTM)
23.23%
Free cash flow per share (TTM)
0.189
Growth
Revenue change (TTM)
-11.41%
Earnings per share change (TTM)
-87.97%
3-year revenue growth (CAGR)
-3.54%
10-year revenue growth (CAGR)
-10.93%
3-year earnings per share growth (CAGR)
-6.05%
10-year earnings per share growth (CAGR)
-20.27%
What the Analysts think about Assertio
Analyst ratings (Buy, Hold, Sell) for Assertio stock.
Assertio Financial Performance
Revenues and expenses
Assertio Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Assertio stock?
Assertio (ASRT) has a market cap of $78M as of September 15, 2025.
What is the P/E ratio for Assertio stock?
The price to earnings (P/E) ratio for Assertio (ASRT) stock is 0 as of September 15, 2025.
Does Assertio stock pay dividends?
No, Assertio (ASRT) stock does not pay dividends to its shareholders as of September 15, 2025.
When is the next Assertio dividend payment date?
Assertio (ASRT) stock does not pay dividends to its shareholders.
What is the beta indicator for Assertio?
Assertio (ASRT) has a beta rating of 0.35. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.